AHN; Hyea Kyung

Patent Applications and Registrations

Patent applications and USPTO patent grants for AHN; Hyea Kyung.The latest application filed is for "antibody binding to fcrn for treating autoimmune diseases".

Company Profile

4.4.8

AHN; Hyea Kyung - Gyeonggi-do KR
Ahn; Hyea-Kyung - Kyunggi-do KR
Ahn; Hyea Kyung - Sungnam-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20200109201 - KIM; Sung Wuk ; et al.	2020-04-09
Antibody binding to FcRn for treating autoimmune diseases Grant 10,544,226 - Kim , et al. Ja	2020-01-28
Antibody binding to FcRn for treating autoimmune diseases Grant 10,336,825 - Kim , et al.	2019-07-02
Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20190135917 - KIM; Sung Wuk ; et al.	2019-05-09
Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20170210801 - Kim; Sung Wuk ; et al.	2017-07-27
Antibody Binding To Fcrn For Treating Autoimmune Diseases App 20170210805 - Kim; Sung Wuk ; et al.	2017-07-27
Uses of modified human tumor necrosis factor receptor-1 polypeptide Grant 9,580,490 - Kim , et al. February 28, 2	2017-02-28
Uses Of Modified Human Tumor Necrosis Factor Receptor-1 Polypeptide App 20150119338 - Kim; Sung Wuk ; et al.	2015-04-30
Process for Purifying Human Thrombopoietin with High Content of Sialic Acid App 20070264710 - Ahn; Hyea-Kyung ; et al.	2007-11-15
Human thrombopoietin comprising glycosylation sited at residues 157 and 164 Grant 7,037,491 - Chung , et al. May 2, 2	2006-05-02
Novel human thrombopoietin mutein App 20050186603 - Chung, Joo Young ; et al.	2005-08-25
Novel human thrombopoietin mutein App 20030228666 - Chung, Joo Young ; et al.	2003-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.